| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |